Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Sep 19, 2023
Open Peer Review Period: Sep 19, 2023 - Nov 14, 2023
Date Accepted: Apr 18, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

Yuan Y, Mei Y, zhao s, Dai S, Liu X, Sun X, Fu Z, Zhou L, Ai J, Ma L, Jiang m

Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

JMIR Med Inform 2024;12:e52934

DOI: 10.2196/52934

PMID: 38973192

PMCID: 11228134

Data flow construction and quality evaluation of electronic source data in clinical trials:Pilot study based on Hospital Electronic Medical Records in China

  • YanNan Yuan; 
  • Yun Mei; 
  • shuhua zhao; 
  • ShengLong Dai; 
  • XiaoHong Liu; 
  • XiaoJing Sun; 
  • ZhiYing Fu; 
  • LiHeng Zhou; 
  • Jie Ai; 
  • LiHeng Ma; 
  • min Jiang

ABSTRACT

Background:

The traditional clinical trial data collection process requires a Clinical Research Coordinator (CRC) who is authorized by the investigators to read from the hospital electronic medical record. Using electronic source data opens a new path to extract subjects' data from EHR and transfer directly to EDC (often the method is referred to as eSource ).The eSource technology in clinical trial data flow can improve data quality without compromising timeliness. At the same time, improved data collection efficiency reduces clinical trial costs.

Objective:

Explore how to extract clinical trial-related data from hospital electronic health record system (EHR), transform the data into an electronic data capture system (EDC) required format, and transfer it into sponsor's environment. Evaluate the transferred datasets to validate the availability, completeness, and accuracy of building eSource dataflow.

Methods:

A prospective clinical trial study registered on the "Drug Clinical Trial Registration and Information Disclosure Platform (http://www.chinadrugtrials.org.cn/) " was selected, and the production data environment of EHR relied on to extract the structured data of four Case Report Form(CRF) data modules: demographics, vital signs, local laboratory, and concomitant medications from EHR. Extracted data was mapped & transformed, de-identified, and transferred to the sponsor’s environments. Data validation was performed based on availability, completeness and accuracy.

Results:

In a secure and controlled data environment, clinical trial data was successfully transferred from a hospital EHR to sponsor's environment with 100% transcriptional accuracy, but availability and completeness could be improved.

Conclusions:

Data availability is low due to some fields required in EDC not being available directly in the EHR. Concurrently, some data is still in unstructured data format and paper-based medical record data, therefore data completeness in the EHR is low. The top-level design of eSource and the construction of hospital electronic data standards should help lay a foundation for full electronic data flow from EHR to EDC in future.


 Citation

Please cite as:

Yuan Y, Mei Y, zhao s, Dai S, Liu X, Sun X, Fu Z, Zhou L, Ai J, Ma L, Jiang m

Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

JMIR Med Inform 2024;12:e52934

DOI: 10.2196/52934

PMID: 38973192

PMCID: 11228134

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.